Background: Irish patients demonstrate a high prevalence of risk for venous thromboembolism. This risk increases with age. The aim of this study was to evaluate our management protocol for older adults presenting on clinical suspicion of deep venous thrombosis, its prevalence in this age group and current treatment used in our setting. Methods: Retrospective data was obtained from older adults who attended the AMAU on clinical suspicion of DVT from September 2015 to May 2016. Information collated included risk factors, Wells score, D-dimer assay, duplex ultrasonography results and treatment. Patients risk for DVT was scored as either high or low.
Results: 95 older adults were included in the study period; mean age was 76.2 ± 6.7 years (range 65-94 years). 69.5% were female. The risk for DVT was high in 81.3% patients however, DVT was diagnosed in 18.9% patients. Median D-Dimer was 5.81 mcg/ml in patients with DVT while median D-dimer was 0.98 mcg/ml in patients without DVT. Median Wells score was 4 in patients with DVT compared to median Wells score of 2 in those without DVT. 61.1% patients were treated with novel oral anticoagulants (NOACs) compared to 11.1% patients who were treated with warfarin. None of the patients in the low-risk group with normal D-dimer concentrations (≤0.50 mcg/ ml) had DVT. Conclusion: DVT was diagnosed in 18.9% of older adults assessed for clinical suspicion of DVT in our AMAU. Higher D-dimer concentrations and Wells score tended towards a positive diagnosis for DVT. Our practice shows the previously documented reluctance to use NOACs for treatment of DVT may no longer be a concern as it was prescribed in 61.1% of our patients. iii13
